The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...
Safari Park, San Diego Zoo and SeaWorld have not seen any of the animals in their collections infected in the three years ...
Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, ...
Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.
21h
Vietnam Investment Review on MSNAIM Vaccine s mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials AI Enabled mRNA Major Vaccine Product Development AcceleratesAIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results